Enzymatica AB (publ) (STO:ENZY)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.960
-0.090 (-4.39%)
Mar 5, 2026, 5:03 PM CET
-32.41%
Market Cap 475.76M
Revenue (ttm) 53.90M
Net Income (ttm) -51.89M
Shares Out 242.74M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 117,396
Average Volume 101,416
Open 1.960
Previous Close 2.050
Day's Range 1.950 - 2.050
52-Week Range 1.600 - 5.450
Beta 0.38
RSI 58.18
Earnings Date Feb 18, 2026

About Enzymatica AB

Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden. [Read more]

Sector Healthcare
Founded 2007
Employees 20
Stock Exchange Nasdaq Stockholm
Ticker Symbol ENZY
Full Company Profile

Financial Performance

In 2025, Enzymatica AB's revenue was 53.90 million, an increase of 18.27% compared to the previous year's 45.58 million. Losses were -51.89 million, -2.42% less than in 2024.

Financial Statements

News

There is no news available yet.